Q4 2014 13F Holders as of 12/31/2014
-
Type / Class
-
Equity / Common Stock par value $0.012 per share
-
Shares outstanding
-
41M
-
Number of holders
-
4
-
Total 13F shares, excl. options
-
1.12K
-
Shares change
-
-19.2K
-
Total reported value, excl. options
-
$6K
-
Value change
-
-$155K
-
Number of sells
-
-5
-
Price
-
$5.33
Significant Holders of ORAMED PHARMACEUTICALS INC. - Common Stock par value $0.012 per share (ORMP) as of Q4 2014
9 filings reported holding ORMP - ORAMED PHARMACEUTICALS INC. - Common Stock par value $0.012 per share as of Q4 2014.
ORAMED PHARMACEUTICALS INC. - Common Stock par value $0.012 per share (ORMP) has 4 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1.12K shares
of 41M outstanding shares and own 0% of the company stock.
Largest 10 shareholders include Citadel Advisors LLC (6.92K shares), Tower Research Capital LLC (TRC) (405 shares), HABERER REGISTERED INVESTMENT ADVISOR INC (334 shares), SEI INVESTMENTS CO (208 shares), SIMPLEX TRADING, LLC (175 shares), CITIGROUP INC (0 shares), Ameriprise Financial Inc (0 shares), LADENBURG THALMANN FINANCIAL SERVICES INC (0 shares), Commerzbank Aktiengesellschaft /FI (0 shares), and AWM Investment Company, Inc. (409K shares).
This table shows the top 4 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.